BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Association of Pulmonary Advanced Practice Providers (APAPP) - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Association of Pulmonary Advanced Practice Providers (APAPP)
X-ORIGINAL-URL:https://www.pulmapp.com
X-WR-CALDESC:Events for Association of Pulmonary Advanced Practice Providers (APAPP)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Krasnoyarsk
BEGIN:STANDARD
TZOFFSETFROM:+0700
TZOFFSETTO:+0700
TZNAME:+07
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220325
DTEND;VALUE=DATE:20220327
DTSTAMP:20261028T062407
CREATED:20220124T095223Z
LAST-MODIFIED:20220124T095545Z
UID:15313-1648166400-1648339199@www.pulmapp.com
SUMMARY:Cleveland Clinic Advanced Diagnostic Bronchoscopy Workshop CME
DESCRIPTION:Expert presenters will discuss the most recent diagnostic tests and procedures along with how they can be used to prevent delays in diagnosis and to eliminate more invasive tests and their accompanying complications. The faculty will focus on improving knowledge and skills with endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA)\, guided bronchoscopy with radial probe ultrasound\, electromagnetic navigation\, and robotic bronchoscopy. In addition\, how to use convex probe EBUS for the concurrent diagnosis and staging of suspected lung cancer to reduce high procedure-related complications and a larger number of invasive procedures will be discussed. \nImportantly\, the organizers provide hands-on sessions during which participants can practice use of EBUS-TBNA\, electromagnetic navigation\, robotic bronchoscopy\, real-time CABT (C-arm based tomography) navigation\, and insertion of indwelling pleural catheter\, all under the guidance of experts in these fields. \n15.75 (7.75 for lectures only as an internet live activity) AMA PRA Category 1 Credits™ \n15.75 (7.75 for lectures only) ABIM MOC points \n15.75 (7.75 for lectures only) ANCC contact hours \nVenue: Loews Portofino Bay Hotel
URL:https://www.pulmapp.com/event/15313/
LOCATION:Loews Portofino Bay Hotel\, Orlando\, FL\, United States
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2022/01/CC_4c-CME.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220317
DTEND;VALUE=DATE:20220318
DTSTAMP:20261028T062407
CREATED:20210615T120247Z
LAST-MODIFIED:20210615T120247Z
UID:15149-1647475200-1647561599@www.pulmapp.com
SUMMARY:Strategies to Improve Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease
DESCRIPTION:More than 200 species of nontuberculous mycobacteria exist that produce both pulmonary and extrapulmonary disease\nAccording to the National Managed Care Claims Database (Optum)\, the prevalence of NTM-LD is increasing\, and approximately 27 million individuals have the disease\nRisk factors for NTM-LD include underlying conditions (eg\, CF/CFTR anomalies\, AAT anomalies\, COPD\, pneumoconiosis\, collagen vascular disease\, bronchiectasis\, TNF alpha antagonists\, alveolar proteinosis\, chronic aspiration)\, significant environmental exposures (eg\, aerosolized soil and water\, endemic areas)\, and innate host issues (eg\, postmenopausal women\, thin women with distinct body habitus\, predisposition to hypersensitivity)\nDifferent clinical phenotypes for nodular/bronchiectatic and fibrocavitary NTM-LD disease include age\, sex\, body type\, and smoking status\nMedian time from symptom onset to diagnosis is 10 months with a range of 1 month to 6 years\nAccording to the 2020 ATS/ERS/ESCMID/IDSA clinical practice guidelines for NTM-LD\, a 3-drug\, macrolide-containing regimen is recommended and can be administered intermittently (noncavitary) or daily (cavitary); parenteral amikacin (including amikacin liposome inhalation solution) or streptomycin is suggested in patients with cavitary\, extensive bronchiectatic\, or macrolide-resistant disease\nIn patients who meet the diagnostic criteria for NTM-LD\, treatment should be started (ie\, rather than watchful waiting)\, especially in the context of positive acid-fast bacilli sputum smears and/or cavitary lung disease\nFactors related to disease progression include bacterial load (ie\, smear positive) and radiographic extent of disease; other predictors are older age\, low BMI (< 18.5)\, comorbidities\, low albumin\, anemia\, and elevated inflammatory indices\nPatients face many challenges with NTM-LD and experience real fears and struggles and losses in quality of life; it is important to share goals\, set expectations\, and provide education on adverse event management
URL:https://www.pulmapp.com/event/strategies-to-improve-diagnosis-and-treatment-of-nontuberculous-mycobacterial-lung-disease/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/06/email-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220303
DTEND;VALUE=DATE:20220305
DTSTAMP:20261028T062407
CREATED:20220124T094845Z
LAST-MODIFIED:20250802T011147Z
UID:15311-1646265600-1646438399@www.pulmapp.com
SUMMARY:10TH ANNUAL LUNG CANCER SYMPOSIUM - VIRTUAL MEETING
DESCRIPTION:This symposium\, presented by Jane and Leonard Korman Respiratory Institute — Jefferson Health and National Jewish Health\, will offer participants the opportunity for a comprehensive update in lung cancer while interacting with state-of-the-art faculty and reviewing actual cases. \nOn the agenda: \n\nKeynote address: Advances in Lung Cancer Biology: Implications\nKeynote address: Role of Surgery in Stage IIIA Disease\nKeynote address: An Update on Immunotherapy\nNew Screening Criteria\nLung Cancer Prevention and Control in Philadelphia\nNational Lung Cancer Round Table (NLCRT) and Lung Cancer Screening\nLung Cancer Journey: A Patient Perspective\nPromoting Lung Cancer Screening Awareness Across the US\nWhat We Can Learn from Breast Cancer Screening\nAddressing Health Disparities\nManaging Lung Cancer Screening Through the COVID Pandemic\nOrganizing a Centralized Program\nAdvances in Surgery\nUpdate on Diagnostic Techniques\n\nOptional Pre-Conference Modules related to lung cancer screening among vulnerable populations and smoking cessation – 2.5 AMA PRA Category 1 Credits™ \n11.75 AMA PRA Category 1 Credits
URL:https://www.pulmapp.com/event/10th-annual-lung-cancer-symposium-virtual-meeting/
LOCATION:Virtual
CATEGORIES:Cancer
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2022/01/TJ.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220224
DTEND;VALUE=DATE:20220227
DTSTAMP:20261028T062407
CREATED:20211028T060912Z
LAST-MODIFIED:20220820T172016Z
UID:15234-1645660800-1645919999@www.pulmapp.com
SUMMARY:15th International Conference Neonatal & Childhood Pulmonary Vascular Disease
DESCRIPTION:[vc_row][vc_column][vc_column_text]This conference will bring together international experts to explore current understanding of the basic pathobiology as well as new and future therapies for neonatal\, pediatric\, and adult pulmonary vascular diseases.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
URL:https://www.pulmapp.com/event/15th-international-conference-neonatal-childhood-pulmonary-vascular-disease/
LOCATION:Hilton San Francisco\, San Francisco\, California
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2021/01/UCSF.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220218
DTEND;VALUE=DATE:20220221
DTSTAMP:20261028T062407
CREATED:20220124T094637Z
LAST-MODIFIED:20250802T013633Z
UID:15308-1645142400-1645401599@www.pulmapp.com
SUMMARY:2022 Celebration of Pediatric Pulmonology and Sleep
DESCRIPTION:This course\, sponsored by the American Academy of Pediatrics and CHEST features nationally prominent faculty presenting topics that highlight current issues in pediatric pulmonology and sleep medicine. The course combines lectures\, interactive seminars\, and Q&A sessions allowing the opportunity to interact directly with faculty. \nOn the agenda: \n\nMolecular Mechanisms of Allergic Asthma\nVaping\, E-Cigarettes and Lung Injury\nNormal and Abnormal Sleep in Infants\nAerodigestive Referral: Who\, Why and When?\nNew Thoracic Imaging: Diagnostic\nCFTR Modulating Drugs\nCystic Fibrosis Diagnostic Dilemmas: CRMS (CFSPID)\, CFRD\, and Interpreting the NBS\nBiologic Medications in Asthma\nFungal Diseases of the Lung\nAerodigestive Disorders: What We’re\nSeeing\, What We’re Doing About Them\nFetal Surgery Interventions\nSleep Disorders Other than OSA\nCongenital Abnormalities of the Lung\nPediatric Chest Trauma\nCOVID-19 in Children\nABPA and Hypersensitivity Pneumonitis\nThe Microbiome in Cystic Fibrosis\nNew Antibiotics in Cystic Fibrosis: IV and Inhaled?\nAllergy Testing: RAST and ImmunoCAP vs Scratch Testing\nPulmonary Nodules: When to Worry\nControl of Breathing Basics\nNon-modulator Therapies for Cystic Fibrosis: Inflammation\, Infection and Nutrition\nHow Does Immunotherapy Work? Is OIT Effective?\nHome (or non-lab) Sleep Study Options\nThe Embryology of Congenital Pulmonary Malformations\nBasics of Polysomnography\, CPAP and BPAP\nAsthma Basics\nSleep Hygiene: Teens and Screens\nBasic CXR Interpretation (ABCDE)\nFunctional Respiratory Disorders\nVaccine Essentials: Schedules/Exceptions
URL:https://www.pulmapp.com/event/2022-celebration-of-pediatric-pulmonology-and-sleep-2/
LOCATION:DoubleTree Resort by Hilton Hotel Paradise Valley – Scottsdale\, Scottsdale\, AZ\, United States
CATEGORIES:Pediatrics,Sleep
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/04/CHEST-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220218
DTEND;VALUE=DATE:20220221
DTSTAMP:20261028T062407
CREATED:20211028T060711Z
LAST-MODIFIED:20250802T013712Z
UID:15231-1645142400-1645401599@www.pulmapp.com
SUMMARY:2022 Celebration of Pediatric Pulmonology and Sleep
DESCRIPTION:This course features nationally prominent faculty presenting topics that highlight current issues in pediatric pulmonology and sleep medicine. The course combines lectures\, interactive seminars\, and Q&A sessions allowing the opportunity to interact directly with faculty. \nOn the agenda: \n\nMolecular Mechanisms of Allergic Asthma\nVaping\, E-Cigarettes and Lung Injury\nNormal and Abnormal Sleep in Infants\nAerodigestive Referral: Who\, Why and When?\nNew Thoracic Imaging: Diagnostic\nCFTR Modulating Drugs\nCystic Fibrosis Diagnostic Dilemmas: CRMS (CFSPID)\, CFRD\, and Interpreting the NBS\nBiologic Medications in Asthma\nFungal Diseases of the Lung\nAerodigestive Disorders: What We’re\nSeeing\, What We’re Doing About Them\nFetal Surgery Interventions\nSleep Disorders Other than OSA\nCongenital Abnormalities of the Lung\nPediatric Chest Trauma\nCOVID-19 in Children\nABPA and Hypersensitivity Pneumonitis\nThe Microbiome in Cystic Fibrosis\nNew Antibiotics in Cystic Fibrosis: IV and Inhaled?\nAllergy Testing: RAST and ImmunoCAP vs Scratch Testing\nPulmonary Nodules: When to Worry\nControl of Breathing Basics\nNon-modulator Therapies for Cystic Fibrosis: Inflammation\, Infection and Nutrition\nHow Does Immunotherapy Work? Is OIT Effective?\nHome (or non-lab) Sleep Study Options\nThe Embryology of Congenital Pulmonary Malformations\nBasics of Polysomnography\, CPAP and BPAP\nAsthma Basics\nSleep Hygiene: Teens and Screens\nBasic CXR Interpretation (ABCDE)\nFunctional Respiratory Disorders\nVaccine Essentials: Schedules/Exceptions\n\n18 AMA PRA Category 1 Credits™\, ABP MOC points
URL:https://www.pulmapp.com/event/2022-celebration-of-pediatric-pulmonology-and-sleep/
LOCATION:Double Tree Resort by Hilton Hotel Paradise Valley\, Scottsdale\, Arizona
CATEGORIES:Pediatrics,Sleep
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/04/CHEST-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220218
DTEND;VALUE=DATE:20220220
DTSTAMP:20261028T062407
CREATED:20211028T060453Z
LAST-MODIFIED:20241029T032013Z
UID:15229-1645142400-1645315199@www.pulmapp.com
SUMMARY:27th Annual Advances in Diagnosis and Treatment of Sleep Apnea and Snoring
DESCRIPTION:Faculty includes international leaders in sleep medicine & surgery. \nTopics: \n\nHome and In-hospital Sleep Studies\nHypoglossal Nerve Stimulation\nNovel Surgical Techniques\nTransoral Robotic Surgery (TORS)\nCPAP Tracking Systems\nAutoPAP\nObesity Treatments – Diet\, Medication\, and Bariatric Surgery\nOral Appliance Therapy\nDriving and OSA\nUpper Airway Evaluation\nDrug-Induced Sleep Endoscopy (DISE)\nComplementary and Alternative Medicine\nOSA in the Elderly\nEvaluation of Sleepiness and Narcolepsy\nInsomnia and Periodic Limb Movements\nPediatric OSA\nObesity-Hypoventilation Syndrome\nThe Future of Sleep Medicine\nWearables\nThe Role of APPs\n\nFormat: Lectures\, keynote addresses\, panel discussions\, Pro-Con debates\, breakout sessions\, and Q&A sessions.
URL:https://www.pulmapp.com/event/27th-annual-advances-in-diagnosis-and-treatment-of-sleep-apnea-and-snoring/
LOCATION:Grand Hyatt\, San Francisco\, California
CATEGORIES:Sleep
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2021/01/UCSF.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220215
DTEND;VALUE=DATE:20220216
DTSTAMP:20261028T062407
CREATED:20220124T094022Z
LAST-MODIFIED:20220124T094022Z
UID:15304-1644883200-1644969599@www.pulmapp.com
SUMMARY:2022 UPMC Shadyside Virtual Pulmonary Conference
DESCRIPTION:This virtual by Microsoft TEAMS conference includes 7 speakers discussing the most up-to-date concepts and research relevant to nurses and other healthcare workers who care for patients with a variety of pulmonary problems. \nTopics: \n\nAdvantages of Robotic Assisted vs Conventional Lung Surgery\nCOVID-19 Survivors: What Are We Seeing and Hearing from Survivors 2 Years after the Start of This Pandemic\nCOVID-19 & Vaccine Update\nSocial Media: Posting\, Privacy\, etc.\nTerminal Extubation: Process from Start to Finish\nLegal Issues within Healthcare
URL:https://www.pulmapp.com/event/2022-upmc-shadyside-virtual-pulmonary-conference/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/01/UPMC.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220213
DTEND;VALUE=DATE:20220218
DTSTAMP:20261028T062407
CREATED:20220124T094251Z
LAST-MODIFIED:20220124T094251Z
UID:15305-1644710400-1645142399@www.pulmapp.com
SUMMARY:38th Annual Children's National Symposium: ECMO and the Advanced Therapies for Cardiovascular and Respiratory Failure
DESCRIPTION:This conference\, sponsored by Children’s National Hospital\, Division of Neonatology\, will address the educational needs of health care workers involved in the care of neonatal\, pediatric and adult patients in respiratory and/or cardiac failure. \nTopics will encompass innovative technologies related to Neonatal\, Pediatric and Adult Extracorporeal Life Support (ECLS). Presentations will include simulation development\, mechanical circulatory support\, nitric oxide and ventilation techniques. \nDidactic instruction combined with panel discussions and short research presentations will enhance the audience’s knowledge in the latest treatments of respiratory and/or cardiac failure and pathophysiology of diseases. Outcome data along with limitations and complications of new therapies will be presented and discussed by experts in the field. Format: Lectures\, breakout sessions (Update on Fetal and Neonatal Treatment of the CDH Patient; Adult ECLS – Update on Treatment and Outcomes; Quality Improvement in ECLS Programs; Advanced Technology in ECLS; Burnout – Team Support Programs)\, Pro-Con debate (Hot Topics in Pediatric Cardiac Critical Care/ECLS)\, How Do I session\, cases presentations\, Ethics session: case presentations & open discussions.
URL:https://www.pulmapp.com/event/38th-annual-childrens-national-symposium-ecmo-and-the-advanced-therapies-for-cardiovascular-and-respiratory-failure/
LOCATION:Keystone Conference Center\, Keystone\, CO
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2022/01/Childrens-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220212
DTEND;VALUE=DATE:20220213
DTSTAMP:20261028T062407
CREATED:20211028T060300Z
LAST-MODIFIED:20211028T060300Z
UID:15226-1644624000-1644710399@www.pulmapp.com
SUMMARY:Innovations in the Treatment of Upper Airway Disorders: What's New in 2022?
DESCRIPTION:Learning Objectives: \n\nDescribe the latest innovations in surgery for endobronchial malignancies\nRecognize the relationship between COVID-19 and tracheal stenosis\nSummarize how experts use minimally-invasive approaches to treat upper airway disorders\nDiscuss and apply future trends in management and treatment and implications for this field clinical practice\n\n3.5 AMA PRA Category 1 Credits™ – maximum
URL:https://www.pulmapp.com/event/innovations-in-the-treatment-of-upper-airway-disorders-whats-new-in-2022/
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/10/rush.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220202
DTEND;VALUE=DATE:20220206
DTSTAMP:20261028T062407
CREATED:20220124T093836Z
LAST-MODIFIED:20250802T004236Z
UID:15303-1643760000-1644105599@www.pulmapp.com
SUMMARY:44th Annual Pulmonary and Allergy Update at Keystone
DESCRIPTION:The Pulmonary and Allergy Update highlights insights and recent advances in pulmonary medicine\, asthma\, allergy and immunology\, presented by faculty from the leading respiratory hospital in the nation. Network with colleagues and nationally recognized experts\, and learn the latest updates on management and treatment options. Workshops and small-group sessions provide great opportunities to discuss key issues and interesting cases with colleagues and National Jewish Health faculty. \n14.75 AMA PRA Category 1 Credits™ – maximum \n14.75 CNE contact hours \nVenue: Keystone Conference Center \nDate\nFebruary 2-5\, 2022 \nLocation\nKeystone\, Colorado 80435\, United States
URL:https://www.pulmapp.com/event/44th-annual-pulmonary-and-allergy-update-at-keystone-2/
LOCATION:Keystone Conference Center\, Keystone\, CO
CATEGORIES:Allergies
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/01/National-Jewish-Health.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220123
DTEND;VALUE=DATE:20220127
DTSTAMP:20261028T062407
CREATED:20211028T055859Z
LAST-MODIFIED:20211028T055859Z
UID:15222-1642896000-1643241599@www.pulmapp.com
SUMMARY:A Research Reboot of Tuberculosis on the Keystone Symposia 50th Anniversary
DESCRIPTION:In this Keystone Symposia the organizers will showcase the outstanding breakthroughs in TB research in the 50 years since the Keystone Symposia founding while highlighting current advances. Because of their current promise\, special attention will be given to the results of recent vaccine trials as well the discovery and implementation of improved antibiotic regimens. Also emphasized will be exciting advances in basic understanding of the host-pathogen interaction\, in particular\, in the area of immunometabolism\, that are leading to the identification of new host-directed treatment targets. The current state of global tuberculosis will be reviewed as well as the impact of viral pandemics on tuberculosis research and control and on the achievement of ultimate goal of TB eradication.
URL:https://www.pulmapp.com/event/a-research-reboot-of-tuberculosis-on-the-keystone-symposia-50th-anniversary/
LOCATION:Beaver Run Resort\, Breckenridge\, Colorado
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/10/KS-Logo-Reverse-NoTag.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220117
DTEND;VALUE=DATE:20220121
DTSTAMP:20261028T062407
CREATED:20211028T055642Z
LAST-MODIFIED:20211028T055642Z
UID:15219-1642377600-1642723199@www.pulmapp.com
SUMMARY:Respiratory viruses: New Frontiers 2022
DESCRIPTION:This Keystone Symposia conference will focus on novel insights into respiratory virus biology that may ultimately lead to more effective prevention and treatment strategies. In many cases\, these novel insights are made possible by new tools that are now available to study pathogens whose infectious cycle is largely restricted to the airways. New information about virus-host interactions will be discussed\, as well as the interplay among diverse microorganisms present in the host airways. The long-term ramifications of respiratory virus infections beyond acute disease will be explored along with both recent successes and failures in prevention and treatment. This conference is a joint symposium with Viral Immunity: Basic Mechanisms and Therapeutic Applications and will have a few combined sessions.
URL:https://www.pulmapp.com/event/respiratory-viruses-new-frontiers-2022/
LOCATION:Keystone Resort\, Keystone\, Colorado
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/10/KS-Logo-Reverse-NoTag.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211208
DTEND;VALUE=DATE:20211209
DTSTAMP:20261028T062407
CREATED:20211028T055351Z
LAST-MODIFIED:20211028T055351Z
UID:15218-1638921600-1639007999@www.pulmapp.com
SUMMARY:Update in Pulmonary Fibrosis: IPF\, COVID-19 and Beyond
DESCRIPTION:The course is a 4-hour virtual conference with five-30 minute presentations on Interstitial Lung Disease and one-hour long panel discussion where challenging cases of ILD are discussed.\nTARGET AUDIENCE\n\n\n\nThis course is designed for physicians\, physician assistants\, nurse practitioners\, and nurses. \n\n\n\n\n\nLEARNING OBJECTIVES\n\n\n\nFollowing completion of this activity\, learners will be able to: \n\nIdentify conditions associated with pulmonary fibrosis.\nDescribe the mechanisms leading to pulmonary fibrosis onset and progression.\nInterpret the impact of pulmonary fibrosis on symptoms\, pulmonary function\, and mortality.\nDescribe best practices for the early and accurate diagnosis of Interstitial Lung Disease.\nDiscuss the follow-up of patients with Interstitial Lung Disease.\nEvaluate evidence-based strategies and emerging therapies for the pharmacologic and non-pharmacologic treatment of ILD.\nExamine the factors and management of pulmonary fibrosis in patients with COVID-19.
URL:https://www.pulmapp.com/event/update-in-pulmonary-fibrosis-ipf-covid-19-and-beyond/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/02/TJU-HSKMC-HR-247x70-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211201
DTEND;VALUE=DATE:20211204
DTSTAMP:20261028T062407
CREATED:20211028T055132Z
LAST-MODIFIED:20250802T013720Z
UID:15215-1638316800-1638575999@www.pulmapp.com
SUMMARY:2021 Pediatric Sleep Medicine Virtual Conference
DESCRIPTION:This biennial\, virtual in 2021\, conference aims to bring together a multidisciplinary group of basic and clinical researchers\, clinicians\, educators\, policy makers\, and trainees involved in pediatric and adolescent sleep medicine. The conference represents an exceptional opportunity to network\, share knowledge and ideas\, and establish collaborative projects. \nDecember 1 – Pediatric Polysomnography: A Master Class. Topics include diagnosis and management of infant sleep disordered breathing\, artificial ventilatory management for patients with PHOX2B mutation confirmed congenital central hypoventilation syndrome (CCHS)\, optimal use of PAP masks and other equipment in pediatric populations\, testing for narcolepsy & idiopathic hypersomnia\, and high flow cannula vs PAP in the management of pediatric sleep disordered breathing. 3.75 AMA PRA Category 1 Credits™ \nDecember 2 – Best Practices Course & Pediatric Behavioral Sleep Workshop. Topics: Pediatric OSA\, pediatric narcolepsy\, parasomnia diagnosis and management\, restless legs syndrome\, restless sleep disorder\, circadian rhythm disorders\, best practices in pediatric insomnia; case presentations: bedtime problems and night wakings in young children\, insomnia and depression in adolescents\, insomnia in autism spectrum disorders\, adapting behavioral interventions for socio-demographically diverse populations\, non-24 hour circadian rhythms in adolescents\, PAP adherence for children with OSA. Also\, roundtable breakouts and quick-fire panel discussion. 3.75 AMA PRA Category 1 Credits™ \nDecember 3 – Pediatric Sleep Medicine Meeting. 5.75 AMA PRA Category 1 Credits™
URL:https://www.pulmapp.com/event/2021-pediatric-sleep-medicine-virtual-conference/
LOCATION:Virtual
CATEGORIES:Pediatrics,Sleep
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/10/Brown.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211129
DTEND;VALUE=DATE:20211203
DTSTAMP:20261028T062407
CREATED:20211028T054910Z
LAST-MODIFIED:20211028T054910Z
UID:15212-1638144000-1638489599@www.pulmapp.com
SUMMARY:WASOG (World Association for Sarcoidosis and Other Granulomatous Disorders) / AASOG (Proceedings of the Americas Association of Sarcoidosis and Other Granulomatous Diseases) 2021: Multidisciplinary Meeting for Sarcoidosis and ILD
DESCRIPTION:WASOG/AASOG 2021\nThe scientific program of the conference includes the latest information regarding the pathogenesis\, diagnosis and treatment of sarcoidosis and interstitial lung diseases. International recognized experts will share their experience with us during this 4-day\, live stream scientific event. \nBy attending this conference\, participants will be able to:\n\nSummarize the evidence on managing patients with fibrotic interstitial lung disease including diagnostic techniques and antifibrotic and immunosuppressive therapies.\nClinically review the diagnostic dilemmas\, utility of diagnostic testing\, and usefulness of therapies to identify and manage cardiac sarcoidosis.\nDescribe how granulomatous and nongranulomatous inflammation leads to fibrosis.\nReview the current knowledge of genetics and genomics in sarcoidosis and interpret its implications for clinical practice.\nReview efficacy and side effect profiles for treatments used to manage sarcoidosis.\nDefine disability in sarcoidosis using WASOG criteria and describe instruments for assessment\, survey results\, and occupational medicine perspectives.\nSummarize the most recent data affecting clinical practice for patients with sarcoidosis.\n\nWhy Join the Live Stream?\n\nLearn about cutting-edge advances in parenchymal lung disease and cardiac sarcoidosis\nParticipate in discussion-focused format with ample time for live question and answer sessions\nConnect with faculty during our consult the professor session to solve clinical conundrums\nNetwork with fellow participants and faculty during breaks through our virtual platform\nJoin an interdisciplinary audience of practitioners and healthcare professionals who seek to learn the latest developments in sarcoidosis and interstitial lung diseases\nCan’t attend the live stream? Registrants receive access to the recordings\, post-course\n\nWho Should Attend?\nPractitioners and healthcare professionals who seek to learn the latest developments in sarcoidosis and interstitial lung diseases\, including pulmonologists\, cardiologists\, pulmonary critical care specialists\, nurse practitioners\, residents and fellows.
URL:https://www.pulmapp.com/event/wasog-world-association-for-sarcoidosis-and-other-granulomatous-disorders-aasog-proceedings-of-the-americas-association-of-sarcoidosis-and-other-granulomatous-diseases-2021-multidisciplinary-me/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2021/10/CC.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Krasnoyarsk:20211114T080000
DTEND;TZID=Asia/Krasnoyarsk:20211114T150000
DTSTAMP:20261028T062407
CREATED:20211109T171317Z
LAST-MODIFIED:20211109T173903Z
UID:15253-1636876800-1636902000@www.pulmapp.com
SUMMARY:2021 PCE Pulmonary Bootcamp
DESCRIPTION:  \nPCE PULMONARY BOOTCAMP\n\nSunday\, November 14\, 2021\n10:00 am ET | 9:00 am CT | 7:00 am PT \nABOUT THIS CE/CME LIVE STREAM\nKeep your pulmonary practice up to date! Get the latest insights into managing diseases of the respiratory tract from a panel of national expert faculty as they bring you the latest updates and clinical perspectives on management of asthma\, COPD\, pulmonary arterial hypertension\, and excessive daytime sleepiness in obstructive sleep apnea. Created specifically for the clinical needs of NPs and PAs in pulmonary medicine\, with practical perspectives and case study reviews. Live streamed for your convenience—all from the comfort of your home or office. \n\nTOPICS INCLUDE\nAsthma\, COPD\, Excessive Daytime Sleepiness\, and Pulmonary Arterial Hypertension\nRegistered Participants—Submit your case studies and have them discussed by our panel of experts! \n\n 
URL:https://www.pulmapp.com/event/2021-pce-pulmonary-bootcamp/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211112
DTEND;VALUE=DATE:20211113
DTSTAMP:20261028T062407
CREATED:20211028T054626Z
LAST-MODIFIED:20211028T054626Z
UID:15208-1636675200-1636761599@www.pulmapp.com
SUMMARY:14th Annual Earl E. Bakken Symposium 2021: Cardiopulmonary Thromboembolic Disease: Insights and Innovations
DESCRIPTION:This symposium will be offered as a hybrid (in-person or virtual via Zoom webinar) experience due to COVID-19 pandemic spread. \nOn the agenda: \n\nEtiology\, Acute Assessment\, and Anticoagulation Strategies\nSurgical Approaches and Innovation for Acute PE\nInterventional Radiology in Acute PE\nPathogenesis of CTEPH: Insights from Large Animal Models\nDiagnosis and Medical Management of CTEPH\nPulmonary Balloon Angioplasty of CTEPH: Past\, Present\, and Future\nPulmonary Thromboendarterectomy for CTEPH: Past\, Present\, and Future\nECMO and Intubation Steroids\, Bethesda Experience\nECMO and North-South Syndrome\nLung Transplantation and COVID-19\n\n6 AMA PRA Category 1 Credits™ – maximum
URL:https://www.pulmapp.com/event/14th-annual-earl-e-bakken-symposium-2021-cardiopulmonary-thromboembolic-disease-insights-and-innovations/
LOCATION:McNamara Alumni Center or Live Zoom Webinar\, Minneapolis\, Minnesota
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/10/Min.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211112
DTEND;VALUE=DATE:20211113
DTSTAMP:20261028T062407
CREATED:20211028T054307Z
LAST-MODIFIED:20250802T004422Z
UID:15205-1636675200-1636761599@www.pulmapp.com
SUMMARY:Asthma Education Summit 2021
DESCRIPTION:This activity will gather health care providers\, community members\, school representatives\, and other community-based organizations for the purpose of disseminating asthma information and promoting asthma education.\n\n\n\n\n\nTarget Audience\n\n\n\nThis activity is designed for physicians\, healthcare professionals\, school representatives and community-based organizations dedicated to the identification and treatment of asthma.\n\n\n\n\n\nLearning Objectives\n\n\n\nAt the conclusion of this activity\, participants will be able to: \n\n\nState how comorbid asthma affects other health issues;\n\n\nDescribe how environmental factors impact asthma;\n\n\nIdentify modifying factors that can help children mitigate the impact of environmental factors on asthma;\n\n\nRecall how vaping impacts youth with asthma and the resources available reduce its negative effects;\n\n\nDiscuss the benefits of conducting and participating in research and how to recruit research participants.
URL:https://www.pulmapp.com/event/asthma-education-summit-2021/
LOCATION:Virtual
CATEGORIES:Asthma
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/10/Chic-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211104
DTEND;VALUE=DATE:20211106
DTSTAMP:20261028T062407
CREATED:20210827T093354Z
LAST-MODIFIED:20210827T093354Z
UID:15185-1635984000-1636156799@www.pulmapp.com
SUMMARY:
DESCRIPTION:Experts in pulmonology and critical care medicine from the University of Michigan Medical School will present a two-day virtual program for physicians and allied health care professionals that outlines the most current treatment information for patients with pulmonary complications. Combining case-based information\, research studies\, and common practice\, presentations and hands-on workshops will focus on airway procedures\, sleep medicine\, and challenges seen in critical care. After this activity\, participants will recognize and manage post intensive care syndrome. \nOn the agenda: \n\nManagement of Chronic Hypercarbic Respiratory Failure\nUpdate in Lung Cancer: What Do We Pulmonologists Need to Know?\nUpdate in Interventional Pulmonology Burden of Early COPD\nUpdates to the Asthma Guidelines and New Approaches to Managing Asthma\nRespiratory Health in a Changing Climate\nInterstitial Lung Disease: A Multi-Disciplinary Discussion\nInnovation in the Time of COVID-19\nCOVID ARDS: Themes and Descants\nThe Problems of Winning: Getting Patients Ready for Life After the ICU\nUpdates in Sepsis\nThe Lost Airway: Prevention & Management\nMAP-ping a Course Out of Shock: Best Practices in Vasopressor Use\nNeurologic Emergencies in the ICU\n\n8 AMA PRA Category 1 Credits™ – maximum \n8 ABIM MOC points
URL:https://www.pulmapp.com/event/15185/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/08/michigan.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211104
DTEND;VALUE=DATE:20211106
DTSTAMP:20261028T062407
CREATED:20210827T093055Z
LAST-MODIFIED:20210827T093055Z
UID:15183-1635984000-1636156799@www.pulmapp.com
SUMMARY:2021 Nontuberculous Mycobacteria (NTM) Lecture Series for Providers
DESCRIPTION:Topics: \n\nEpidemiology of NTM\nEnvironmental Sources of NTM\nGenomic Approaches to Investigate Nontuberculous Mycobacteria\nHost Susceptibility\nChallenging Cases\nMycobacterial lab\nRadiologic Evaluation of Pulmonary NTM Infections\nTreatment of Slow Growing Mycobacteria\nTreatment of Rapidly Growing Mycobacteria\nSurgical Management\nEmerging therapies in NTM Pulmonary Disease\nDrug Side Effects\nBronchiectasis\nCystic Fibrosis Related NTM Infections\nExtrapulmonary NTM
URL:https://www.pulmapp.com/event/2021-nontuberculous-mycobacteria-ntm-lecture-series-for-providers/
LOCATION:National Jewish\, Molly Blake Conference Center\, Denver\, CO\, United States
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/01/National-Jewish-Health.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211027
DTEND;VALUE=DATE:20211028
DTSTAMP:20261028T062407
CREATED:20211028T060047Z
LAST-MODIFIED:20250802T004230Z
UID:15225-1635292800-1635379199@www.pulmapp.com
SUMMARY:44th Annual Pulmonary and Allergy Update at Keystone
DESCRIPTION:
URL:https://www.pulmapp.com/event/44th-annual-pulmonary-and-allergy-update-at-keystone/
LOCATION:Keystone Conference Center\, Keystone\, CO
CATEGORIES:Allergies
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/01/National-Jewish-Health.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211017
DTEND;VALUE=DATE:20211221
DTSTAMP:20261028T062407
CREATED:20210827T092742Z
LAST-MODIFIED:20210827T092742Z
UID:15182-1634428800-1640044799@www.pulmapp.com
SUMMARY:CHEST 2021 Annual Meeting
DESCRIPTION:Expert faculty presentations\, simulated learning experiences\, education games\, and much more will be available to all participants. As always\, CHEST 2021 will be team-focused\, giving participants the opportunity to learn and improve their skill sets as a team. Health care providers in all stages of their careers will benefit from knowledge updates and clinical research presentations. An amazing opportunity to network and reconnect with colleagues.
URL:https://www.pulmapp.com/event/chest-2021-annual-meeting/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/04/CHEST-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211007
DTEND;VALUE=DATE:20211010
DTSTAMP:20261028T062407
CREATED:20210827T085604Z
LAST-MODIFIED:20210827T085604Z
UID:15165-1633564800-1633823999@www.pulmapp.com
SUMMARY:Pulmonary Manifestations of Connective Tissue Disorders
DESCRIPTION:Mayo Clinic’s Pulmonary Manifestations of Connective Tissue Disorders at the Ritz-Carlton in Orlando\, Florida is a three-day CME course designed to provide pulmonologists\, rheumatologists\, internists and general practitioners up-to-date information on pulmonary manifestations of rheumatologic disorders. From this course\, participants discern how to recognize and diagnose interstitial lung disease\, pulmonary hypertension and other respiratory problems which are common in autoimmune rheumatologic disorders\, and review the latest information regarding pathogenic mechanisms\, clinical trials and therapeutic modalities. The speakers are nationally and internationally recognized specialists in the field. Residents and fellows have the opportunity to participate by submitting original studies for poster presentations.
URL:https://www.pulmapp.com/event/pulmonary-manifestations-of-connective-tissue-disorders/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/01/Mayo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210930
DTEND;VALUE=DATE:20211004
DTSTAMP:20261028T062407
CREATED:20210827T092337Z
LAST-MODIFIED:20210827T092337Z
UID:15179-1632960000-1633305599@www.pulmapp.com
SUMMARY:Eastern Pulmonary Conference
DESCRIPTION:EPC blends the interactivity characteristic of small regional conferences together with the cutting edge science characteristic of large national meetings. The educational goal is to share clinically relevant information which improves the diagnostic accuracy and the effectiveness of treatments with practitioners who treat pulmonary diseases. \nOn the agenda: \n\nUpdate on cough guidelines\nMolecular phenotyping of asthma\nAlarmins: Gateway to inflammation\nTreatment and “overtreatment” of hypoxemic respiratory failure\nUpdate on nosocomial pneumonia\nLiberation from mechanical ventilation in critically ill adults\nAntibiotic resistance: Issues for the intensivist and pulmonologist\nPBL – Uncontrolled asthma: Gaining control\nPro/Con debate: Are short-acting beta agonists obsolete? The GINA Model\nAir travel and the pulmonary patient\nHypersensitivity pneumonitis: Current concepts of pathogenesis & potential treatment targets\nAntifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis\nInterstitial Lung Disease (ILD)\nEvolution of PF: From ILA’s to UIIP and everything in between\nPro/Con: Redefining the diagnosis of COPD\nLung nodules: Approaches to integrate imaging\, biomarkers\, risk and guidelines\nResilience during the COVID -19 Pandemic\nTHORACIC POCUS: Current trends and perspectives of point of care ultrasound\nCOVID-19: Lessons clinicians have learned from the pandemic\nAdvances in Nontuberculous Mycobacterial Lung Disease: Improvement in Diagnosis\, Treatment and Patient Quality of Life\nUpdate on Anti-PD-1 Targeted Therapies for the Management of Patients with NSCLC\nPulmonary Arterial Hypertension Management
URL:https://www.pulmapp.com/event/eastern-pulmonary-conference-2/
LOCATION:The Breakers Palm Beach\, 1 S County Rd\,\, Palm Beach\, Florida\, 33480
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210930
DTEND;VALUE=DATE:20211001
DTSTAMP:20261028T062407
CREATED:20210615T115732Z
LAST-MODIFIED:20250802T004433Z
UID:15144-1632960000-1633046399@www.pulmapp.com
SUMMARY:Deconstructing Difficult-to-Treat Asthma in the Age of Targeted Biologic Therapies
DESCRIPTION:Severe asthma is defined as uncontrolled asthma despite optimal therapy and appropriate management of comorbidities; it affects up to 10% of adults with asthma\nIt is now broadly classified into 2 distinct endotypes based on the level of Th2-mediated inflammation:\n\nT2-high asthma is driven first by epithelial alarmins\, including IL-25\, IL-33\, and TLSP\, then by Th2-cytokines\, namely IL-4\, IL-5\, and IL-13\, and may include either a robust eosinophil or allergic response\nIn contrast\, T2-low asthma is driven by Th1 and Th17 cells\, IL-6\, IL-8 and IL-17\, and a neutrophilic or paucigranulocytic response\n\n\nTargets for biologic therapy for T2-high asthma include IgE\, the IL-5 signaling pathway\, and the IL-4R\n\nOmalizumab targets circulating IgE\nMepolizumab and reslizumab target circulating IL-5\nBenralizumab targets the α subunit of the IL-5R\nDupilumab targets the α subunit of the IL-4R\, which is involved in IL-4 and IL-13 signaling\n\n\nClinically relevant biomarkers for selecting a biologic agent include serum IgE level (omalizumab)\, blood eosinophil level (all 5 agents)\, and fraction of exhaled nitric oxide or FeNO (omalizumab and dupilumab)\nPatients with OCS-dependent asthma are also considered to have T2-high asthma; dupilumab is approved for this indication\, and other biologics have demonstrated efficacy in such patients as well\nCurrently no targeted therapies are approved for T2-low asthma; tiotropium\, macrolide antibiotics\, bronchial thermoplasty\, and/or low-dose OCS may be considered
URL:https://www.pulmapp.com/event/deconstructing-difficult-to-treat-asthma-in-the-age-of-targeted-biologic-therapies/
LOCATION:Online
CATEGORIES:Asthma
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/06/Email-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210923
DTEND;VALUE=DATE:20210925
DTSTAMP:20261028T062407
CREATED:20210827T091824Z
LAST-MODIFIED:20210827T091824Z
UID:15175-1632355200-1632527999@www.pulmapp.com
SUMMARY:Rare Genetic Causes of Bronchiectasis: Paving the Way for Interventional Trials
DESCRIPTION:This conference will bring together clinical and translational investigators in rare genetic causes of bronchiectasis\, including primary ciliary dyskinesia (PCD)\, primary immunodeficiencies (PID)\, alpha-1 anti-trypsin disease (AATD) and cystic fibrosis (CF)\, to discuss preparing for collaborative multicenter clinical trials. In this day and a half-long conference presenters will address critical knowledge gaps in disease pathogenesis\, clinical trial preparedness and overcoming barriers to successful trials in these rare disease patient populations. Speakers will provide state-of-the-art updates on the diagnosis and major sources of morbidity in these conditions\, as well as commonalities and differences in bronchiectasis pathogenesis\, with an emphasis on potential therapeutic targets. Lessons learned from previous clinical trials\, particularly in CF\, will be presented\, in order to capitalize on previous experience as we plan future clinical trials. The strengths and weaknesses of potential clinical trial endpoints will be discussed. Innovative study designs for rare diseases and partnering with stakeholders will be highlighted. Junior investigators will be invited to participate in special sessions regarding career development and funding opportunities. Patients and families will have the opportunity to participate in “Meet the Expert” sessions. \nAlso\, on the agenda: \n\nMucous Rheology & Mucus Clearance\nAirway Inflammation and Oxidative Stress\nMicrobiome and Respiratory Infection\nDysregulated Immunity (Innate and Adaptive)\nLung function: Spirometry & Lung Clearance Index\n\n8.75 AMA PRA Category 1 Credits™ – maximum \nVenue: Children’s Hospital Colorado
URL:https://www.pulmapp.com/event/rare-genetic-causes-of-bronchiectasis-paving-the-way-for-interventional-trials/
LOCATION:Children\, Aurora\, CO\, United States
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2021/08/CHOC.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210920
DTEND;VALUE=DATE:20210924
DTSTAMP:20261028T062407
CREATED:20210314T092131Z
LAST-MODIFIED:20250205T201416Z
UID:6122-1632096000-1632441599@www.pulmapp.com
SUMMARY:Aspen Lung Conference
DESCRIPTION:The 63rd Annual Thomas L. Petty Aspen Lung Conference\nWill convene at the Gant Conference Center in Aspen\, Colorado with a virtual/in-person hybrid format. The theme of the conference will be “ARDS in the 21st Century: New Insights into Clinical and Mechanistic Heterogeneity.” \nThe Acute Respiratory Distress Syndrome (ARDS) represents a common syndrome arising from numerous\, heterogeneous\, and often-independent disease processes.  Accordingly\, a single ARDS study drug\, if uniformly applied to all patients regardless of underlying disease pathophysiology\, would likely fail to consistently improve patient outcomes. For clinical studies to overcome this obstacle\, a new appreciation of ARDS mechanistic and phenotypic heterogeneity is required\, enabling future precision medicine approaches to the recognition and treatment of lung injury. \nThe 2021 Thomas L. Petty Aspen Lung Conference will integrate basic\, translational\, and clinical approaches to address the impact of ARDS heterogeneity\, with a focus on (1) understanding the presence and therapeutic significance of ARDS mechanistic and phenotypic subtypes\, (2) exploring multi-cellular and multi-systemic mechanisms responsible for this heterogeneity\, and (3) determining how to best account for disease heterogeneity during clinical trial design and outcome assessment. Heterogeneity within COVID-19 ARDS\, as well as between COVID-19 and non-COVID-19 ARDS\, will also be discussed. \nThis conference will provide an international forum bringing together leading basic\, translational\, and clinical ARDS researchers while welcoming trainees in pulmonology and critical care medicine\, with the goal of identifying shared interests that will lead to more productive research and more effective personalized therapies. Finally\, the varied scientific themes and therapeutic strategies emerging during the conference will be reconciled in a concluding Conference Summary presented by Dr. Thomas Martin (University of Washington).
URL:https://www.pulmapp.com/event/aspen-lung-conference-2/
LOCATION:Aspen\, Colorado\, Aspen\, CO\, United States
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/03/CU.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210908
DTEND;VALUE=DATE:20210915
DTSTAMP:20261028T062407
CREATED:20210827T091444Z
LAST-MODIFIED:20250802T011155Z
UID:15172-1631059200-1631663999@www.pulmapp.com
SUMMARY:IASLC 2021 World Conference on Lung Cancer (WCLC21)
DESCRIPTION:This conference will be offered as a safe virtual experience due to COVID-19 pandemic spread. \nThe World Conference on Lung Cancer (WCLC)\, organized by the International Association for the Study of Lung Cancer (IASLC)\, is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. \nThe IASLC’s 2021 meetings will include both live streaming event with virtual interactions and on-demand content
URL:https://www.pulmapp.com/event/iaslc-2021-world-conference-on-lung-cancer-wclc21/
LOCATION:Virtual
CATEGORIES:Cancer
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/08/WCLC21-Logo_0820.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210905
DTEND;VALUE=DATE:20210909
DTSTAMP:20261028T062407
CREATED:20210827T091018Z
LAST-MODIFIED:20210827T091018Z
UID:15169-1630800000-1631145599@www.pulmapp.com
SUMMARY:European Respiratory Society (ERS) International Congress 2021
DESCRIPTION:This virtual annual congress is a showcase of excellence across the entire field of respiratory medicine. \nFormat: Postgraduate courses – week-long virtual events October 11-15 (lecture-based sessions include dedicated time for interaction between participants and faculty; 100 participants per session)\, Challenging Clinical Cases sessions\, Game Zone (interactive space with individual skills stations\, and an online game-based platform)\, HERMES European examinations (knowledge-based and are comprised of 90 multiple-choice questions each)\, Lungs on Fire sessions (led by two discussants who will present the cases to a panel of experts and the audience)\, lunchtime Meet the Expert sessions (an expert will stimulate discussion\, answer questions and offer advice – more personal approach to learning; limited to 40 participants)\, Professional Development workshops (aimed to provide team leaders\, supervisors)\, Skills workshops (32 participants per workshop + fee)\, case-based skills workshops (50 participants per workshop + fee)\, Patient forum (looks at the best ways healthcare professionals can relay information to respiratory patients)\, Respiratory Championship (four teams battling).
URL:https://www.pulmapp.com/event/european-respiratory-society-ers-international-congress-2021/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2021/08/ERS.png
END:VEVENT
END:VCALENDAR